• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Universal Genetic Testing to Identify Pathogenic Germline Variants in Patients With Cancer-Reply.

作者信息

Esplin Edward D, Samadder N Jewel

机构信息

Invitae, San Francisco, California.

Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona.

出版信息

JAMA Oncol. 2021 Jul 1;7(7):1071-1072. doi: 10.1001/jamaoncol.2021.1012.

DOI:10.1001/jamaoncol.2021.1012
PMID:34014282
Abstract
摘要

相似文献

1
Universal Genetic Testing to Identify Pathogenic Germline Variants in Patients With Cancer-Reply.用于识别癌症患者致病种系变异的通用基因检测——回复
JAMA Oncol. 2021 Jul 1;7(7):1071-1072. doi: 10.1001/jamaoncol.2021.1012.
2
Universal Genetic Testing to Identify Pathogenic Germline Variants in Patients With Cancer.通过全基因组检测识别癌症患者的致病性种系变异
JAMA Oncol. 2021 Jul 1;7(7):1070. doi: 10.1001/jamaoncol.2021.1002.
3
Universal Genetic Testing to Identify Pathogenic Germline Variants in Patients With Cancer.采用通用基因检测识别癌症患者的致病性种系变异
JAMA Oncol. 2021 Jul 1;7(7):1071. doi: 10.1001/jamaoncol.2021.1005.
4
Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: .战胜癌症需要进行全面的生殖系和肿瘤基因组检测：
J Clin Oncol. 2023 Jun 10;41(17):3100-3103. doi: 10.1200/JCO.22.02833. Epub 2023 Mar 17.
5
Most patients with cancer are not undergoing germline genetic testing.大多数癌症患者未接受种系基因检测。
CA Cancer J Clin. 2024 Jan-Feb;74(1):6-7. doi: 10.3322/caac.21827.
6
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.通过对肿瘤和正常DNA中癌症相关基因进行通用测序与基于指南的种系检测对晚期癌症患者进行突变检测
JAMA. 2017 Sep 5;318(9):825-835. doi: 10.1001/jama.2017.11137.
7
Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.采用治疗为导向的肿瘤测序筛查胚系癌症易感性。
J Mol Diagn. 2021 Sep;23(9):1145-1158. doi: 10.1016/j.jmoldx.2021.06.006. Epub 2021 Jun 29.
8
Sharing genetic test results of germline pathogenic variants of hereditary cancer with relatives: A single-center cross-sectional study.将种系致病性遗传性癌症基因突变检测结果与亲属共享：一项单中心横断面研究。
Jpn J Clin Oncol. 2021 Oct 5;51(10):1547-1553. doi: 10.1093/jjco/hyab110.
9
Yes, We Can, But Should We? Ethical Considerations in Reporting Germline Findings From Paired Tumor-Normal Genomic Testing in Patients With Advanced Cancer.是的，我们能够做到，但我们应该这样做吗？晚期癌症患者配对肿瘤-正常基因组检测中种系结果报告的伦理考量
J Clin Oncol. 2023 Apr 10;41(11):1982-1985. doi: 10.1200/JCO.22.00796. Epub 2022 Dec 5.
10
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.前瞻性研究胰腺腺癌新发病例中的种系基因检测。
Cancer. 2018 Sep 1;124(17):3520-3527. doi: 10.1002/cncr.31628. Epub 2018 Aug 1.

引用本文的文献

1
Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer.结直肠癌患者普遍接受检测后，进行种系基因检测的医疗政策前后对比。
JAMA Netw Open. 2022 Oct 3;5(10):e2238167. doi: 10.1001/jamanetworkopen.2022.38167.
2
Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.乳腺癌患者进行通用种系基因检测的临床实用性。
JAMA Netw Open. 2022 Sep 1;5(9):e2232787. doi: 10.1001/jamanetworkopen.2022.32787.
3
Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer.
实体肿瘤癌症患者遗传性癌症综合征的通用种系基因检测
JCO Precis Oncol. 2022 Sep;6:e2100516. doi: 10.1200/PO.21.00516.